Roche Executive Linked Chronic Disease to Economic Risks
A senior official at the firm argued that systemic healthcare shifts are necessary to sustain global productivity.
Updated on Sept. 25, 2026 in Healthcare
Live Poll
Do you believe increased investment in healthcare innovation is a reliable driver of national economic growth?
Roche executive Jörg Rupp has identified non-communicable diseases as a critical global economic challenge. Rupp advocated for a transition toward continuous care models to address conditions that currently account for 43 million deaths annually.
Why it matters
Poor health outcomes result in productivity losses of up to 15 percent of global GDP each year. Healthy populations are vital to financing future healthcare systems and ensuring long-term economic stability.
Roche reported CHF 61.5 billion in group sales and CHF 12 billion in research and development investment for 2025. Additionally, the company processed 31 billion diagnostics tests over the same period.
The players
Jörg Rupp
Jörg Rupp is a senior executive at Roche who focuses on addressing global healthcare challenges.
Roche
Roche is a multinational healthcare company headquartered in Basel that specializes in pharmaceuticals and diagnostics.
The details
Rupp noted that while 12,900 medicines are in development, half of the world's population lacks access to essential services. Innovation targeting genetic and lifestyle factors is essential as the global population aged over 65 is projected to triple by 2050.
Timeline
September 25, 2026: Jörg Rupp spoke at a media dialogue.
2025: Roche reported group sales and R&D figures.
2040: Projected economic gain of $12 trillion in global GDP.
2050: Global population over 65 is projected to triple.
Market Landscape
This strategy marks a departure from historic acute-care focused responses by emphasizing continuous, long-term disease management. It positions Roche to capitalize on the increasing global demand for integrated healthcare solutions as demographic aging shifts market requirements.
Patients may see a shift in treatment approaches as providers adopt continuous care models rather than strictly acute interventions. These changes aim to improve long-term health outcomes and overall accessibility to modern medicine.
The takeaway
Proactive investment in healthcare innovation yields an estimated $7 return for every $1 spent on prevention. Implementing these models is essential for mitigating the economic burden of chronic illness on the global workforce.
Further reading
Explore the Healthcare section for more on industry trends and innovation.
Source note: This article includes information reported by @businessline.
Live Poll
Do you believe increased investment in healthcare innovation is a reliable driver of national economic growth?
